AFT strikes deal with Poland’s Mercapharm

8 April 2021 - Deborah Wilkes

Premium

New Zealand’s AFT Pharmaceuticals has signed a licensing agreement for its Maxigesic combination painkiller with Polish company Mercapharm. The company has also revised its financial guidance following delays and disruptions related to the COVID-19 pandemic.

Click tags below for more information on topics:

AFT

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: